Imagiologically aggressive presentation of paediatric multiple sclerosis.
作者信息
Barradas Pedro, Esteireiro Ana Sofia, Palavra Filipe, Carvalho Silvia
机构信息
Medical Image Department, Neuroradiology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Paediatrics Department, Centro Hospitalar do Oeste, Unidade de Caldas da Rainha, Caldas da Rainha, Portugal
出版信息
BMJ Case Rep. 2020 Feb 18;13(2):e234148. doi: 10.1136/bcr-2019-234148.
Abstract
摘要
相似文献
1
Imagiologically aggressive presentation of paediatric multiple sclerosis.儿童多发性硬化症的影像学侵袭性表现
BMJ Case Rep. 2020 Feb 18;13(2):e234148. doi: 10.1136/bcr-2019-234148.
2
Neurite orientation dispersion and density imaging discloses early changes in the normal-appearing white matter in paediatric multiple sclerosis.神经突方向离散度与密度成像揭示小儿多发性硬化症中正常外观白质的早期变化。
J Neurol Neurosurg Psychiatry. 2022 Mar;93(3):332-334. doi: 10.1136/jnnp-2021-326355. Epub 2021 Jul 16.
3
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly - No.MRI上无症状的新病灶是复发，应相应进行治疗——错误。
Mult Scler. 2019 Dec;25(14):1843-1845. doi: 10.1177/1352458519845111. Epub 2019 Nov 1.
4
An asymptomatic new lesion on MRI is a relapse and should be treated accordingly - Yes.MRI上无症状的新病灶即为复发，应相应进行治疗——是。
Mult Scler. 2019 Dec;25(14):1842-1843. doi: 10.1177/1352458519855723. Epub 2019 Nov 1.
5
Significant clinical worsening after natalizumab withdrawal: Predictive factors.停药后出现显著临床恶化：预测因素。
Mult Scler. 2015 May;21(6):780-5. doi: 10.1177/1352458514549401. Epub 2014 Nov 12.
6
Two-year regional grey and white matter volume changes with natalizumab and fingolimod.那他珠单抗和芬戈莫德治疗 2 年的区域性灰质和白质体积变化。
J Neurol Neurosurg Psychiatry. 2020 May;91(5):493-502. doi: 10.1136/jnnp-2019-322439. Epub 2020 Feb 28.
7
Asymptomatic progressive multifocal leukoencephalopathy: a case report and review of the literature.无症状性进行性多灶性白质脑病：一例报告并文献复习
J Med Case Rep. 2018 Jul 1;12(1):187. doi: 10.1186/s13256-018-1727-7.
8
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.复发缓解型多发性硬化症患者接受那他珠单抗治疗第一年期间的白质扩散变化
AJNR Am J Neuroradiol. 2016 Jun;37(6):1030-7. doi: 10.3174/ajnr.A4690. Epub 2016 Mar 10.
9
Tumefactive demyelinating lesions: A comprehensive review.肿胀性脱髓鞘病变：全面综述
Mult Scler Relat Disord. 2017 May;14:72-79. doi: 10.1016/j.msard.2017.04.003. Epub 2017 Apr 9.
10
Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis.在接受那他珠单抗治疗的多发性硬化症患者中，脑脊液中神经丝和tau蛋白水平与脑萎缩相关。
Eur J Neurol. 2017 Jan;24(1):112-121. doi: 10.1111/ene.13162. Epub 2016 Oct 4.
本文引用的文献
1
Pediatric Multiple Sclerosis: an Update.小儿多发性硬化症：最新进展。
Curr Neurol Neurosci Rep. 2018 Sep 18;18(11):76. doi: 10.1007/s11910-018-0886-7.
2
MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.MRI 和实验室特征及国际标准在儿童和青少年多发性硬化症诊断中的表现：一项前瞻性队列研究。
Lancet Child Adolesc Health. 2018 Mar;2(3):191-204. doi: 10.1016/S2352-4642(18)30026-9. Epub 2018 Feb 1.
3
MRI in the evaluation of pediatric multiple sclerosis.磁共振成像在儿童多发性硬化症评估中的应用
Neurology. 2016 Aug 30;87(9 Suppl 2):S88-96. doi: 10.1212/WNL.0000000000002787.
Zotero 插件